Delivery Order SPE2DR25D3303-SPE2DR26F63A2
- Not listed
- The Defense Logistics Agency awarded a $1,926.55 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units). This firm fixed price contract, which is not set-aside, represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,951.06 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with an ultimate completion date of May 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a contract ceiling value of $3,248.74. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,309.12 on August 13, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units. This is a firm fixed price contract with no set-aside designation, awarded competitively through the Defense Logistics Agency's Medical Supply Chain. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.52 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release formulation) in quantities of 100 units. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, carries a firm fixed price and represents a competitively awarded, non-set-aside contract. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,929.51 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate-release formulation) in quantities of 100 units. This competitively awarded, non-set-aside contract carries a firm fixed price and an ultimate completion date of December 10, 2025. The award was issued on December 9, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,694.99 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, awarded on September 24, 2025, carries a firm fixed price structure with an ultimate completion date of September 25, 2025, and is not designated as a set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $598.50 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division on August 16, 2023. Under this order, Amerisourcebergen will provide 100 tacrolimus 1 mg capsules to support the Department of Defense's medical supply needs. The place of performance for this pharmaceutical delivery is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order has an end date of August 17, 2023, indicating delivery of the specified...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of 5 mg Tacrolimus capsules. The $1,903.26 contract has a period of performance through March 22, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is the sole awardee of a $999,999,999.00 indefinite delivery contract from DLA to deliver pharmaceuticals...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F63A2Delivery Order
The Defense Logistics Agency awarded a $1,029.76 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a completion date of December 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. Through its DLA prime contract vehicle, the company fulfills diverse pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Tacrolimus, an immunosuppressant medication commonly used in transplant and autoimmune treatment protocols, exemplifies the company's role in supporting federal medical supply requirements through its established federal contract infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/7/25 |